Tocilizumab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8116 publications

Subcutaneous Tocilizumab in Thyroid Eye Disease: What Can Orbital Surgeons Learn From Borrowed Blueprints?

Subcutaneous Tocilizumab in Thyroid Eye Disease: What Can Orbital Surgeons Learn From Borrowed Blueprints?

Journal: Ophthalmic plastic and reconstructive surgery

Published: September 02, 2026

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.

Journal: Circulation

Published: August 29, 2026

When inflammation is not the driver: Pauci-immune synovitis and the stromal basis of refractory arthritis.

When inflammation is not the driver: Pauci-immune synovitis and the stromal basis of refractory arthritis.

Journal: EULAR rheumatology open

Published: August 28, 2026

Rare manifestations of giant cell arteritis

Rare manifestations of giant cell arteritis

Journal: Lakartidningen

Published: August 27, 2026

Chronic immunomodulatory treatment in MOGAD: Experience in Latin America

Chronic immunomodulatory treatment in MOGAD: Experience in Latin America

Journal: Medicina

Published: August 27, 2026

Association of tocilizumab use with mortality and clinical outcomes in critically ill patients followed in the intensive care unit for COVID-19 pneumonia: a single-center retrospective cohort study.

Association of tocilizumab use with mortality and clinical outcomes in critically ill patients followed in the intensive care unit for COVID-19 pneumonia: a single-center retrospective cohort study.

Journal: Expert review of anti-infective therapy

Published: August 27, 2026

Erratum to: Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease.

Erratum to: Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease.

Journal: Zeitschrift fur Rheumatologie

Published: August 26, 2026

Takayasu Arteritis in a Child with Chronic Active Proctitis of Unspecified Etiology: A Case Report with Diagnostic Challenges and Literature Review.

Takayasu Arteritis in a Child with Chronic Active Proctitis of Unspecified Etiology: A Case Report with Diagnostic Challenges and Literature Review.

Journal: Journal of visualized experiments : JoVE

Published: August 22, 2026

Tocilizumab for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: A matched case-control retrospective study.

Tocilizumab for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: A matched case-control retrospective study.

Journal: Therapeutic advances in respiratory disease

Published: August 20, 2026

Interleukin-6 as a therapeutic target in Diabetic macular edema: current evidence and future perspectives.

Interleukin-6 as a therapeutic target in Diabetic macular edema: current evidence and future perspectives.

Journal: Expert opinion on therapeutic targets

Published: August 15, 2026

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 14, 2026

Recent advances in the medical management of thyroid eye disease.

Recent advances in the medical management of thyroid eye disease.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: August 13, 2026

Showing 1-12 of 8,116

Last Updated: 09/26/2026